Efficacy and Safety of Switching from Entecavir to Tenofovir Alafenamide in Chronic Hepatitis B: A Multicenter Randomized Trial in Korea
Authors:
- Hyunjae ShinHSHyunjae Shin
- Moon Haeng HurMHMoon Haeng Hur
- Yang Hyun BaekYBYang Hyun Baek
- Chun Kyon LeeCLChun Kyon Lee
- Yong Kyun ChoYCYong Kyun Cho
- June Sung LeeJLJune Sung Lee
- Jae Yoon JeongJJJae Yoon Jeong
- Yong Jin JungYJYong Jin Jung
- Ja Kyung KimJKJa Kyung Kim
- Moon Young KimMKMoon Young Kim
- Yeon Seok SeoYSYeon Seok Seo
- Woo Jin ChungWCWoo Jin Chung
Open Access
- 22 April 2026
- journal article
- Published by The Editorial Office of Gut and Liver in Gut and Liver
- Vol. 20 (4) , 636-644
Abstract
Hyunjae Shin, Moon Haeng Hur, Yang Hyun Baek, Chun Kyon Lee, Yong Kyun Cho, June Sung Lee, Jae Yoon Jeong, Yong Jin Jung, Ja Kyung Kim, Moon Young Kim, Yeon Seok Seo, Woo Jin Chung, Moon Soo Koh, Jeong-Han Kim, Yun Bin Lee, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu, Jung-Hwan Yoon, Yoon Jun Kim. Gut and Liver -0001;0:. https://doi.org/10.5009/gnl250479Keywords
Funding Information
- Daewoong Pharmaceutical Company
This publication has 42 references indexed in Scilit:
- Comparison of bone mineral density changes between denosumab and bisphosphonates in tenofovir-exposed chronic hepatitis B patients with osteoporosisOsteoporosis International, 2025
- Metabolic effects and cardiovascular disease risks of antiviral treatments in patients with chronic hepatitis BJournal of Medical Virology, 2024
- Real‐life impact of tenofovir disoproxil fumarate and entecavir therapy on lipid profile, glucose, and uric acid in chronic hepatitis B patientsJournal of Medical Virology, 2022
- Renal safety of tenofovir disoproxil fumarate and entecavir in liver transplant patients: a nationwide Korean registry studyHepatology International, 2022
- Impact of tenofovir alafenamide vs. entecavir on hepatocellular carcinoma risk in patients with chronic hepatitis BHepatology International, 2021
- Tenofovir–disoproxil–fumarate modulates lipid metabolism via hepatic CD36/PPAR-alpha activation in hepatitis B virus infectionJournal of Gastroenterology, 2020
- Tenofovir Versus Entecavir on Recurrence of Hepatitis B Virus–Related Hepatocellular Carcinoma After Surgical ResectionHepatology, 2020
- Statin Use and the Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis BHepatology, 2019
- Risk of Hepatocellular Carcinoma in Patients Treated With Entecavir vs Tenofovir for Chronic Hepatitis BJAMA Oncology, 2019
- Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infectionHepatology, 2012